Women on CagriSema lost 25% of their body weight in a post hoc trial analysis, while 79.6% of users had digestive side effects. The drug is not approved. Ice Water, Math Quizzes, and Shocks: The 1948 ...
Add Yahoo as a preferred source to see more of our stories on Google. Research shows a urine test looking for genetic markers of bladder cancer can more than halve the number of cystoscopies needed to ...
In a trial, Xpert® Bladder Cancer Monitor, a non-invasive urinary biomarker test, appeared suitable for guiding cystoscopy during monitoring of patients with NMIBC. Alternating between cystoscopy and ...
A new urine test could spare bladder cancer survivors from a painful follow-up procedure needed to ensure their cancer hasn't come back, researchers report. People who've gotten surgery for high-risk ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results